VEGFA and neoplasm: GC-MSC-derived angiogenesis can be suppressed by inhibiting the NF-κB/VEGF signaling pathways, which are responsible for the promotion of angiogenesis and the stimulation of VEGF expression in vitro and in vivo in the tumor environment.